Palo Alto, California, United States The company was established in North America in United States. The main office of represented VC is situated in the Palo Alto.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Yamanouchi Venture Capital, startups are often financed by OrbiMed, Yozma Group, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Dansk Innovation, Aravis Ventures. In the next rounds fund is usually obtained by Novartis Venture Fund, Dansk Innovation, Aravis Ventures.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Switzerland. Among the most successful fund investment fields, there are Biotechnology, Wellness. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Evolva.
The increased amount of exits for fund were in 2009. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Yamanouchi Venture Capital works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2005. The fund is constantly included in less than 2 deals per year.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Asheville Angels | Asheville, North Carolina, United States |
| Bualuang Ventures | - |
| Chong Kun Dang Pharmaceutical Corp. | Seoul, Seoul-t'ukpyolsi, South Korea |
| Cowen and Company | New York, New York, United States |
| Dubai 100 | Dubai, United Arab Emirates |
| frogVentures | California, San Francisco, United States |
| Fuxi Touzi | China, Ningbo, Zhejiang |
| GP Capital | China, Shanghai, Shanghai |
| Invitalia | Italy, Lazio, Roma |
| John Lewis & Partners | England, London, United Kingdom |
| Mack-Cali Realty Corporation | Edison, New Jersey, United States |
| Ocean Road Partners | California, United States, Venice |
| Side Door Ventures | - |
| Sprout Capital | Bangalore, India, Karnataka |
| Squadra Ventures | Baltimore, Maryland, United States |
| St. Cloud Capital | California, Los Angeles, United States |
| Tatro Group | - |
| TrustCapital | India, Maharashtra, Mumbai |
| Yamcom Holdings BV | Afula, Israel, North District |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Evolva | $10M | 01 Dec 2006 | Aargau, Switzerland | ||
Evolva | $2M | 21 Mar 2005 | Aargau, Switzerland | ||
Predix Pharmaceuticals | $43M | 27 Jan 2005 | Boston, Massachusetts, United States | ||
Evolva | $14M | 16 Aug 2004 | Aargau, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Evolva | $10M | 01 Dec 2006 | Aargau, Switzerland | ||
Evolva | $2M | 21 Mar 2005 | Aargau, Switzerland | ||
Predix Pharmaceuticals | $43M | 27 Jan 2005 | Boston, Massachusetts, United States | ||
Evolva | $14M | 16 Aug 2004 | Aargau, Switzerland |
